DiaMedica Inc. (DMA)
This is a bio-pharmaceutical enterprise committed to developing novel treatments for diabetes and other disorders. The diabetes programs of the corporation are based on a critical liver nerve signaling mechanism involved in enhancing insulin sensitivity after meal consumption.
Watch the video to learn about the probability of DiaMedica Inc. (DMA) Chart Signal as of Jun 18 2013
Hotstocked Precision will calculate the probabilities of DiaMedica Inc. (DMA)
To see the headquarters in Google Street View &trade, drag this yellow guy: 
over to the red pointer: 
Contact Information:
| Business Address: | 200 - 135 Innovation Drive Winnipeg, Manitoba R3T 6A8 |
| Mailing Address: | 200 - 135 Innovation Drive Winnipeg, Manitoba R3T 6A8 |
| Phone: | 204 477-7590 |
| Email: | rpauls@diamedica.com |
| Website: | - |
Company Details:
| Market Cap: | - |
| Year of Inc: | January 21, 2000 |
| Year Ends: | December 31, 2012 |
| Sector: | - |
| Industry: | consumer products - biotechnology/pharmaceuticals |
| Employees: | - |
| CEO: | - |
MD&A - English June 29, 2011
Interim financial statements/report - English June 29, 2011
52-109FV2 - Certification of interim filings - CEO (E) June 29, 2011
| Post # | Subject | Re | Name | Date |
|---|---|---|---|---|
| There are no comments. | ||||
someone replies to your post?